AMGN Q3'26 Earnings: EPS estimate is 5.79 USD

What happened

Amgen is scheduled to report its third-quarter 2026 results on November 3 after the market closes, with results expected at 4:00 p.m. ET. The supplied estimate is revenue of $10.07 billion and earnings per share, or EPS, of $5.79.

Confirmed

Global impact / market context

The estimates give investors benchmarks for judging whether Amgen’s reported sales and profit per share meet expectations. A shortfall could prompt questions about revenue and costs, while a beat could support confidence in the company’s earnings; the article does not provide actual Q3 results.

Analyst inference

The article lists reported revenue and earnings per share above estimates for the four prior quarters shown. This history offers context, but does not establish whether Amgen will meet the estimates for its upcoming results; a different result could affect views of its revenue and profit outlook.

Analyst inference

What to watch

1. Check Amgen’s Q3 2026 reported revenue against the $10.07 billion estimate; the difference will show whether sales were stronger or weaker than the supplied benchmark. Analyst inference
2. Compare reported earnings per share, or EPS, with the $5.79 estimate; EPS is earnings divided by shares, and a miss may raise questions about costs or profit. Analyst inference
3. Listen for management’s comments on the results and outlook, if provided; the article gives no guidance, so any update could change investors’ expectations for future sales and earnings. Analyst inference

Evidence

• Original source link unavailable